chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Having pain in right arm at injection shot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Having pain in right arm at injection shot) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040AZIA) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Mar-2021, the patient experienced VACCINATION SITE PAIN (Having pain in right arm at injection shot). At the time of the report, VACCINATION SITE PAIN (Having pain in right arm at injection shot) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.  Treatment information was not provided.
Hospitalization; This spontaneous case was reported by a consumer and describes the occurrence of HOSPITALISATION (Hospitalization) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HOSPITALISATION (Hospitalization) (seriousness criterion hospitalization). At the time of the report, HOSPITALISATION (Hospitalization) had resolved. Not Provided          Concomitant products were not provided. Treatment medication were not reported. Patient was hospitalized for 2 to 3 days.  Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
15 minutes after taking VIVOTIF pt developed puritis of throat, mouth and extremities. Also states that she had discomfort with swallowing but states it was not difficult to swallow. Denies SOB, hives. Did not take any treatment as she has had a rxn to an antihistamine in the past. Awoke this morning and puritis had improved overall but still had an itchy tongue, arms and legs and nausea. Pt still did not take any treatment.  Called Clinic, advised to come in. Once here, her VSS, she presented in no acute distress, no hives, SOB, Difficulty swallowing. States puritis continues to improve since this morning. Pt given 12.5 mg liquid Benadryl. Pt states that she completed the oral Typhoid vaccine in 2009 without difficulty.
First shot on April 27th, but never got my second dose./ am 2 months overdue for my second dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (First shot on April 27th, but never got my second dose./ am 2 months overdue for my second dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (First shot on April 27th, but never got my second dose./ am 2 months overdue for my second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (First shot on April 27th, but never got my second dose./ am 2 months overdue for my second dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided. Treatment information was not provided.
Hospitalized 12/30/2021; COVID-19 positive 12/29/2021; fully vaccinated plus booster  BRIEF OVERVIEW: Discharge Provider: DO Primary Care Provider at Discharge: MD Admission Date: 12/30/2021 Discharge Date: 01/03/2022 DETAILS OF HOSPITAL STAY:   PRESENTING PROBLEM: Hyponatremia [E87.1] Sepsis due to pneumonia [J18.9, A41.9] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 84 y.o. male who presents today with progressive symptoms of shortness of breath, congestion, poor appetite and poor intake, general weakness for the past 4-5 days. He tested positive for COVID 19 on December 29th.  Today he was set up for monoclonal antibody therapy which he completed but following this was sent to the ED for further evaluation. Patient lives alone at senior living apartment. He admits he has not been eating due to poor appetite and feels weak to walk. Denies any falls. Does not use walker or cane at baseline. Today his pulse ox reading was 92% so he was sent to the ED for evaluation.  He was noted on arrival to the ED to have temp38.1 and HR 124. He was 90-92% on room air. His significant lab findings include sodium 126. In the emergency department he was given Tylenol, 2.5 mg Haldol, 2 L IV fluid.  His chest x-ray showed linear opacity in the left lung base represented atelectasis versus airspace disease but no new focal lung consolidation.  Patient vent uncomfortable returning to his living facility due to his generalized weakness so opted for observation admission to General Medicine and ongoing care. Hospital course:  Patient was admitted for acute hyponatremia, this improved with IVF. Patient did not complain of shortness of breath immediately after admission and was on room air throughout his stay. WBC was elevated but stable, likely due to steroids. He admitted to increased weakness for which PT/OT was consulted. PT/OT recommended home with assist. Patient felt strong enough for discharge and while lives alone, reported he has help he can call. Outpatient PT was arranged. Patient was discharged to home in improving condition on 1/1/22. He may continue Decadron that was previously prescribed.
flu like symptoms: beginning with body aches and stiffness, then pain at injection site, then feeling of a fever (though no actual fever) with extreme chills, painful injection site, difficulty raising arm. Feelings started around 5 pm; by 8 PM i had to get into bed. By 1 AM started to feel better, then by 7 AM nearly better except still achy and stiff feeling.
Discharge Provider: MD Primary Care Provider: MD Admission Date: 10/16/2022 Discharge Date: Oct 17, 2022  PRESENTING PROBLEM: Weakness [R53.1] COVID-19 virus detected [U07.1]   HOSPITAL COURSE:    88 y.o. female with PMH Endometrial Ca s/p TLH/BSO, cognitive impairment presented with weakness. In emergency department patient saturating well on room air, hemodynamically stable.  Lab significant for COVID-19 positive PCR, urinalysis with 15 squamous cells, chest x-ray negative for acute abnormality.  Patient was given 1 L IV fluid bolus.  Patient admitted for weakness, recurrent falls and likely placement following PT OT evaluation and care management evaluation.  Continue him monitor COVID-19 symptoms for progression.    Patient stayed in hospital for approximately 24 hours.   Patient was monitored and did well.  Stable throughout the 24 hours of stay without any episodes of hypoxia or fevers.  PTOT evaluation completed and recommended home health care.  With patient stable and home safety confirmed, patient was discharged home
BELL'S PALSY OF RIGHT SIDE. 12/03/09 Medical record received for DOS: 10/2/02 and 11/17/09.  DX: Bell's Palsy Pt presented with rt. sided facial weakness and inability to close rt. eye
6MAY98 3PM lt cheek, jaw & neck started to ache-had some vomiting & body aches-may have had a low grade temp;7MAY98 had dentist appt w/? tooth problems exam was negative;rx ATB;
being hot/cold; anxiety symptoms; Heart palitation; feeling bad; Pressure headache; body aches; chills; This spontaneous case was reported by a consumer and describes the occurrence of FEELING OF BODY TEMPERATURE CHANGE (being hot/cold), ANXIETY (anxiety symptoms), PALPITATIONS (Heart palitation), FEELING ABNORMAL (feeling bad) and TENSION HEADACHE (Pressure headache) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 050E21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 24-Sep-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING OF BODY TEMPERATURE CHANGE (being hot/cold), ANXIETY (anxiety symptoms), PALPITATIONS (Heart palitation), FEELING ABNORMAL (feeling bad), TENSION HEADACHE (Pressure headache), MYALGIA (body aches) and CHILLS (chills). At the time of the report, FEELING OF BODY TEMPERATURE CHANGE (being hot/cold), ANXIETY (anxiety symptoms), PALPITATIONS (Heart palitation), FEELING ABNORMAL (feeling bad), TENSION HEADACHE (Pressure headache), MYALGIA (body aches) and CHILLS (chills) outcome was unknown.            No concomitant medications were reported. No treatment medications were reported.   This case was linked to MOD-2021-053194, MOD-2021-053183 (Patient Link).
Information has been received from a female consumer concerning her friend's son who was vaccinated "years ago" with a dose of MMRII. Subsequently, she reported that her friend's son developed autism. Additional information has been requested. Upon internal review, the autism was considered an "Other Medical Event".
Lightheadedness, Dizziness, HTN, patient with severe anxiety, EKG done via EMS, Sinus Tachycardia.
Td admin - LD 15AUG93 am of 16AUG onset of fever to 103, arm very swollen & warm to touch, body aches;
Friday April 09 in the morning began itching in the throat with slight cough, at the end of the night of the same day I started with a fever and chills and I have been with a permanent fever since Friday at midnight between 102 degrees and 99.4. Right now it is at 100.2. I have been taking acetaminophen 1000 mgs every 6 hours since yesterday at noon.
One hour after administration: Dizziness/vertigo. She sat down and became "shaky," developed into rigors. Some throat tightness. Treated with Benadryl 50mg and Tylenol (dose unknown) and O2 nonrebreather mask. Next day full body soreness, "bad headache." Evaluated by Doctor on site.
Patient said she got redness and pain 3 days after vaccination and then she got eczema on her arm.
Received vaccine on 11/6 at about 12:15pm, patient woke up around 2 am on 11/7/19 with swollen face and eyes. She took Benadryl 25 mg otc for a couple days and reported symptoms improved/ almost gone on 11/8/19.
Flare up of Herpes Simplex Virus followed by long term discomfort and weakness in knees.
Shaking; Soreness; Small rash on buttocks; Headaches; Chills; This spontaneous case was reported by a consumer and describes the occurrence of   in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.
Blood pressure shot up within 5 minutes of injection. Fought multiple episodes of fainting. Shaking and dizziness for about 2 hours.
Patient received dose after BUD; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received dose after BUD) and NO ADVERSE EVENT (No adverse event) in an infant patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS1417B) for COVID-19 prophylaxis.     It was reported patient did not had relevant medical history/conditions, allergy, concomitant diseases and risk factor and allergies was unknown disease.     On 09-Jan-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 09-Jan-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received dose after BUD) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received dose after BUD) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient received dose after BUD).    No concomitant medications were reported.  The patient did not receive any other vaccines in the 4 weeks prior to COVID-19 vaccine.  No treatment medications were reported.
PATIENT REPORTED TO  US  ON  05/17/2022.  SHE SAID  3 DAYS AFTER THE SHOT , 10/05/2021, SHE BROKE OUT WITH RASH  ALL OVER HER BODY ACCOMPANIED WITH JOINT PAINS. SHE SAID SHE WAS TREATED WITH STEROID BUT THE CONDITION HAS BEEN ON AND OFF SINCE.
- muscle ache in upper arm and should within first half hour of shot - extreme body aches began that evening; continued throughout the day 1/10; still present morning of 1/11, not as intense - temperature spiked to almost 100 that evening; fluctuated throughout the next day
Vaccine administered improperly-- injected too low-  my daughter having neuropathic pain/ nerve injury, starting almost immediately.
This case was reported by a lawyer and described the occurrence of mercury poisoning in a 7 year old male patient who received hepatitis B vaccine recombinant and diphtheria and tetanus toxoids and pertussis absorbed for prophylaxis. This report was received via the litigation process and a physician or other health care professional has not verified this report. At an unknown time after receiving Hepatitis B vaccine, DTP/DTaP vaccine, Haemophilus vaccine and/or MMR II vaccine, the patient experienced neurotoxic effects resulting in severe neurodevelopmental injuries. The events were attributed to mercury overdose and poisoning resulting from the thimerosal component of the vaccines. The multiple symptoms of the patient's injuries occurred and were first manifest no later than 01/01/2001. According to the attorney, the patient incurred medical expenses and will continue to incur medical expenses in the future as a result of his injuries. The attorney also alleged that the patient suffered significant impairments in his ability to enjoy life, faces significant obstacles to performing the tasks and activities of every day living, and suffers ongoing physical and mental distress. The case was assessed as medically serious (OMIC).
CONGESTION; RUNNY NOSE; SORE THROAT; TENDER LYMPH NODES; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 15-JUL-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 20-JUL-2021, the subject experienced congestion. On 20-JUL-2021, the subject experienced runny nose. On 20-JUL-2021, the subject experienced sore throat. On 20-JUL-2021, the subject experienced tender lymph nodes. On 21-JUL-2021, Laboratory data included: COVID-19 virus test (NR: not provided) Negative. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the congestion, runny nose, sore throat and tender lymph nodes was not reported. This report was non-serious.
5 days post vaccination developed fever, chills, body aches and new legions on groin, burning when urinating. Treated for STI/UTI on antibiotics.  4 days of antibiotic treatment with out relief. Determined to be HSV2 and started on Valacyclovair, swabbed for HSV 1&2 and both are negative. Now new legions located on right knee and right hallux.
Client was given MMRV instead of MMR vaccine along with Varicella vaccine for One year old shots. Writer had mistaken MMRV for MMR vaccine and grabbed wrong vaccine out of the freezer. Client's mother was contacted and explained the situation and educated to monitor client  for adverse reactions or strong immune response.
Patient administered vaccine after the manufacture's date of expiration; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient administered vaccine after the manufacture's date of expiration) in a 68-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 070H21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 08-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 08-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient administered vaccine after the manufacture's date of expiration). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient administered vaccine after the manufacture's date of expiration) outcome was unknown.     For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No Concomitant product use was reported.  The dose administered after 30-day Use by Date or after manufacturer date of expiry. The date the vial was initially stored in the refrigerator was unknown. It was also reported that the vial didn't undergo any temperature excursions.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2022: Live Follow-up received contains non-significant information
Pt recvd vax 16SEP92 & DEC 1992 pt devel swollen lymph nodes; lab eval revealed a high lymphocyte count; pt recvd 3rd dose of vax 15MAR93; No further details were provided;
2/10/21: Woke up with chills, no fever  @5:15am, back to sleep, Temp 99.3F at 10:05am, Tylenol at 10:50am, Temp 100.3F at 5:15pm Temp 101.3F at 9:10pm and took tylenol and regular medications, Temp 100.6F at 10:55pm and went to sleep. 2/11/21: woke up with temp 98.7 at 10:00am, had body aches, red and feverish area where vaccine was given in upper left arm.  The red, itchy and feverish area about 3 inches x 2 inches on upper left arm lasted about 5 days, also got a lump under left arm that lasted about 6 days and all of these went away by 2/17/21. But I've had more fatigue, and shortness of breath  since this 2nd vaccine. Misses my doctor appointment on 2.17/21 due to the winter storm, not going anywhere , we were having all last week.
Patient noticed that she was covered all over her body with a non-itchy rash on Thursday 10/13/2022
After patient receive the vaccine and sitting in the pharmacy waiting area for about 10 minutes, he started to feel dizzy and sweating and he said he felt like he was going to pass out. We call EMS right away. He remained conscious while waiting for ambulance to arrive. Paramedics checked on him and he walked out with paramedics.
Muscle spasms, muscle pain, aching joint pain through-out my body and fatigue.
Developed severe abdominal cramps on my left side around 7 p.m. on Wednesday, April 28. Cramps were intermittent and in varying degrees of intensity. Cramps continued through Friday, April 30 with varying intensity. Attempted to treat with Tylenol and GasX.  Starting around 10:30 a.m. on Saturday May, 1, the pain in my left side increased in intensity and was not waning. After consulting with a telehealth practitioner, I  went to the emergency room and was quickly admitted. My blood and urine were tested, along with CT scans of my body. The CT scan revealed that blood was no longer reaching two parts of my left kidney and I was diagnosed with a arterial thrombosis.   I was fully admitted to the hospital and a heparin drip was immediately started.
Rash, itching, swelling lips and tongue and throat. Helped by Benadryl. Rash was on back, legs and torso lasted few days.
Complaint of headache, runny nose/congestion, loss of taste/smell, and fatigue.
palor became pale; skin diaphoretic;verbalized dizziness; local MD was called;stated it seemed to be from stress; no SOB experienced; hx of fainting; father states is doing fine @ 2PM;
experienced arm soreness after both doses; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A 37 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1), for COVID-19 immunization, reaction(s): "receiving the first dose, the person who injected the needle (i.e., vaccine) did it "wrong" or "at an angle" and made the arm bleed slightly"; Bnt162b2 (Dose1), for COVID-19 immunization, reaction(s): "experienced arm soreness for the next couple of days/ arm soreness after both doses", "receiving the first dose, the person who injected the needle (i.e., vaccine) did it "wrong" or "at an angle" and made the arm bleed slightly". The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "experienced arm soreness after both doses". Additional information: Sister of reporter received the Pfizer COVID-19 booster: Individual experienced vomiting and spiked a high fever, body aches; "felt like she had a stomach virus during the night and one day of flu-like symptoms the next day"; whole body was sore, no localized arm soreness; chills, fever, throwing up. Reporter received Pfizer COVID-19 doses 1 and 2: experienced arm soreness after both doses. When receiving the first dose, the person who injected the needle (i.e., vaccine) did it "wrong" or "at an angle" and made the arm bleed slightly: "went it at an angle" stabbed me a little"; experienced arm soreness for the next couple of days.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Case number PHEH2014US020488, is an initial spontaneous report received from health care professional via pharmacist on 07 Oct 2014. This report refers to a 52 year old female patient. Medical history and concomitant medication was not reported. Current conditions included allergies and smoking. She was vaccinated with FLUCELVAX (batch number: 160233) at a dose of 0.5 ml intramuscular into right deltoid on 01 Oct 2014. On the same day she experienced general malaise, aches and pains. Final outcome of the events was completely recovered. Reporter assessed the events as non-serious. Causality assessment was not reported.
Arm tenderness/ arm tenderness was in her left arm; Arm tenderness/ arm tenderness was in her left arm; This is a spontaneous report from a contactable consumer (patient). A 58-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration, administered in the left arm on 05Mar2021 at 12:00 (batch/lot number: EN6205 and expiry date: Jun2021) at the age of 58 years old, as DOSE 1, SINGLE for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had the first dose of the vaccine on 05Mar2021, and she was fine and didn't really have any symptoms, "just the usual, like you get after you get the flu shot where you have arm tenderness or whatever." The patient reported that the arm tenderness was in her left arm and does not remember when it began, but it began a couple of hours after the vaccine on 05Mar2021 and resolved probably in a day or so. The patient recovered from the event "arm tenderness/ arm tenderness was in her left arm" on Mar2021.